Oramed Pharma (ORMP)
2.30 x 3 2.36 x 26
Pre-market by (Cboe BZX)
2.24 -0.09 (-3.86%) 04/28/25 [NASDAQ]
2.30 x 3 2.36 x 26
Pre-market 2.24 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ORMP | QIPT | FONR | ||
| Company | Oramed Pharma | Quipt Home Medical Corp | Fonar Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.28 | 2.10 | 12.10 | ||
| High | 2.35 | 2.17 | 12.25 | ||
| Low | 2.24 | 2.09 | 12.00 | ||
| Last | 2.24 | 2.12 | 12.24 | ||
| Change | -0.09 | +0.02 | +0.22 | ||
| % Change | -3.86% | +0.95% | +1.83% | ||
| Volume | 124,500 | 48,100 | 19,200 | ||
| 20-Day Average Volume | 80,445 | 134,280 | 15,450 | ||
| Previous Close | 2.33 | 2.10 | 12.02 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.19 | 2.10 | 12.61 | ||
| 20-Day Raw Stochastic | 76.36% | 49.06% | 10.96% | ||
| 20-Day Relative Strength | 49.53% | 44.16% | 36.55% | ||
| Weighted Alpha | -9.32 | -45.17 | -30.00 | ||
| Today's Opinion | 80% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 40% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 48% Sell | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.44% since 04/21/25 | +5.47% since 04/21/25 | +0.66% since 04/21/25 | ||
| Low | 2.23 on 04/22/25 | 2.00 on 04/22/25 | 12.00 on 04/28/25 | ||
| High | 2.35 on 04/28/25 | 2.17 on 04/23/25 | 12.47 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +1.36% since 03/28/25 | -8.62% since 03/28/25 | -11.94% since 03/28/25 | ||
| Low | 1.82 on 04/09/25 | 1.86 on 04/07/25 | 12.00 on 04/28/25 | ||
| High | 2.37 on 04/03/25 | 2.39 on 03/31/25 | 14.19 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -0.44% since 01/28/25 | -33.33% since 01/28/25 | -22.24% since 01/28/25 | ||
| Low | 1.82 on 04/09/25 | 1.86 on 04/07/25 | 12.00 on 04/28/25 | ||
| High | 3.09 on 02/11/25 | 3.27 on 01/31/25 | 17.62 on 02/13/25 | ||
| 6-Month | |||||
| %Chg | -3.45% since 10/28/24 | -23.74% since 10/28/24 | -20.47% since 10/28/24 | ||
| Low | 1.82 on 04/09/25 | 1.86 on 04/07/25 | 12.00 on 04/28/25 | ||
| High | 3.09 on 02/11/25 | 3.27 on 01/31/25 | 17.62 on 02/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 85,785 | 87,906 | 83,106 | ||
| Shares Outstanding, K | 40,850 | 43,091 | 6,211 | ||
| Annual Sales | 0 | 245,920,000 | 102,880,000 | ||
| Annual Net Income | -19,060,000 | -6,760,000 | 10,570,000 | ||
| Last Quarter Sales | 0 | 61,380,000 | 24,950,000 | ||
| Last Quarter Net Income | -10,190,000 | -1,080,000 | 1,960,000 | ||
| 60-Month Beta | 1.50 | 0.65 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 03/27/25 | -0.03 on 02/10/25 | 0.29 on 02/19/25 | ||
| Latest Earnings Date | 05/08/25 | 05/21/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | 0.008 on 03/18/99 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 10.45 | ||